Skip to content
image 35 image 35

Meet Our Precision for Medicine Leadership Teams

We believe an essential element in the success of your project will be the experience of our people
Here are our leaders and experts. Our experience runs as deep as our passion for patients. We are multi-faceted in our breadth of knowledge and collaborate as one team, across functions, to fit the needs of your project. With specialized expertise in the development of complex therapies, we are ready to go to work for you.

Meet our Precision for Medicine Leadership

    • Chad Clark

      Chad Clark

      President

    • Matt-Arnold-1

      Matt Arnold

      President, Translational Sciences

    • Sofia Baig

      Sofia Baig

      President, Clinical Solutions

    • Steve-Empoliti-Photo

      Steve Empoliti

      Chief Commercial Officer

    • John Khoury

      John Khoury

      Executive Vice President, Manufacturing Solutions

    • Tony Khoury

      Tony Khoury

      Executive Vice President, Manufacturing Solutions

    • Anshul-Mangal

      Anshul Mangal

      President, Manufacturing Solutions

    • Scott Marshall

      Scott Marshall, PhD

      President, QuartzBio

    • Deb Phippard

      Deborah Phippard, PhD

      Chief Scientific Officer

    • Harpreet-Singh_Square_Full

      Harpreet Singh, MD

      Chief Medical Officer

    • Sofia Baig

      Sofia Baig

      President

    • Harpreet-Singh_Square_Full

      Harpreet Singh, MD

      Chief Medical Officer

    • Nithiyanandhan-Ananthakrishnan-1

      Nithiya Ananthakrishnan

      Senior Vice President, Biometrics

    • Andrea Cotton

      Andrea Cotton-Berry

      Global Head of Strategic Development

    • Simon-Fleming

      Simon Fleming

      Executive Vice President

    • Carolyn Harley

      Carolyn Harley

      Head Operational Excellence

    • Katie-McGuire

      Katie McGuire

      Senior Vice President, Regulatory and Site Start-Up

    • Clare Fourrier

      Clare Sarvary Fourrier

      Senior Vice President, Clinical Operations

    • SallyAnne Williams

      Sallyanne Williams

      Senior Vice President, Global Head Project Management

    • Matt-Arnold-1

      Matt Arnold

      President

    • Deb Phippard

      Deborah Phippard, PhD

      Chief Scientific Officer

    • YvoneBeasly

      Yvonne Beasley

      Vice President, Global Central Lab Services

    • Joe Bower

      Joe Bower, PhD, MBA

      Senior Vice President, Laboratory Operations

    • Darren Davis

      Darren Davis, PhD

      Senior Vice President

    • Rob Fannon Headshot

      Rob Fannon, MPH, MBA

      General Manager, Biospecimen Solutions

    • Sven Olek

      Sven Olek, PhD

      Senior Vice President, Research

    • Amanda Woodroofe

      Amanda Woodrooffe, PhD

      Senior Vice President, General Manager UK Labs

    • Anshul-Mangal

      Anshul Mangal

      President

    • John Khoury

      John Khoury

      Executive Vice President

    • Tony Khoury

      Tony Khoury

      Executive Vice President

    • Landon-DeCosta

      Landon DeCosta

      Senior Director

    • Daniel-Foody

      Danny Foody

      Director

    • Greg Gara

      Greg Gara

      Senior Vice President

    • Jacob-Greenwood

      Jacob Greenwood

      Vice President

    • Christian-Hermanas

      Christian Hermanas

      Sr. Manager, Precision for Medicine Manufacturing Solutions

    • Kathy-Johnson

      Kathy Johnson

      Director of Human Resources

    • Phillip-Massey1

      Phil Massey

      Senior Director

    • joe-neroni

      Joseph Neroni

      Senior Director

    • Adam-Pfeiffer

      Adam Pfeiffer

      Vice President

    • Austin-Potthoff

      Austin Potthoff

      Manager, Precision for Medicine Manufacturing Solutions

    • Cory-Proctor

      Cory Proctor

      Senior Director

    • Chad-Salisbury

      Chad Salisbury

      Senior Vice President

    • Michelle-Sinsel

      Michelle Sinsel

      Senior Director

    • Sarah-Stoll

      Sarah Stoll

      Senior Director

    • Nathan-Traughber

      Nathan Traughber

      Senior Director

    • Jim-Watson_Square_Full

      Jim Watson

      Vice President

    • Scott Marshall

      Scott Marshall, PhD

      President, QuartzBio

    • Tobias-Guennel

      Tobi Guennel

      Senior Vice President of Product & Chief Architect, QuartzBio

    • Jared Kohler-1

      Jared Kohler

      Senior Vice President of Operations, Project Management, and Customer Success - QuartzBio

    • Messina Wiley

      Messina Wiley

      Senior Vice President of Sales & Marketing - QuartzBio

Chad Clark
Chad Clark

President

Recognized industry leader focused on combining cutting-edge technology, strategic program design, and operational excellence to help life sciences companies effectively address the increasing evidence demands and need to accelerate research initiatives. Previous experience spans the execution of phase I-IV clinical trials, specialty lab services, safety, REMS and patient support services.

Matt-Arnold-1
Matt Arnold

President, Translational Sciences

Strategic, highly collaborative biotechnology industry veteran, driven by opportunities to bring life-changing therapeutics to patients. Over two decades of global, cross-functional biotech and pharmaceutical experience, across both rapid growth and mature organizations, including leadership positions at AVROBIO, AstraZeneca, and Amgen.

Sofia Baig
Sofia Baig

President, Clinical Solutions

Exceptional strategic leader, adept at driving organizational change and delivering top- and bottom-line business growth. Expert in strategic account management, global clinical development operations, and delivering transformational change inclusive of people, processes, and technology. Winner of multiple prestigious awards, including PharmaVoice 100 most inspiring leader in the life sciences industry, and as part of a team, the Catalyst Award for DEI work focused on improving women’s representation in senior leadership.

Steve-Empoliti-Photo
Steve Empoliti

Chief Commercial Officer

Visionary strategic leader, adept at propelling growth by strengthening relationships and enhancing capabilities to better meet customer needs. Driven by the desire to get advanced medicines to patients in need. Brings unique expertise from Fortune 100 companies, combining skills gleaned through commercial leadership, corporate strategy, client development, and global product management for major pharmaceutical companies, and more than a decade of management consulting to the life sciences industry.

John Khoury
John Khoury

Executive Vice President, Manufacturing Solutions

Long-standing biotech/pharmaceutical industry executive and global authority in cell and gene therapy facility builds. Key force in industrializing the world’s largest CGTx manufacturing footprint. Trusted strategic partner in make vs buy analysis, site and vendor selection, tech transfer execution strategies, and facility start-ups. Facilitated partnerships with 100+ life science organizations including startups, established biologics and CGTx innovators. Extensive experience with small and large molecules, including biologics and biosimilars. Dedicated champion for patient advocacy and philanthropy, who leads his team in contributing thousands of volunteer hours in support of patient-focused not-for-profit organizations.

Tony Khoury
Tony Khoury

Executive Vice President, Manufacturing Solutions

Life sciences leader who helped pioneer the industrialization of biologics and advanced therapies. Deep expertise in small and large molecules, honed through work with a range of life science organizations, from start-ups and academic centers to financial institutions and CMOs/CROs. Spearheaded significant global turnkey facility builds, automation, validation, engineering, and serialization track and trace, deploying billions in capital across the life sciences sector. Led the creation of the Advanced Therapy Manufacturing Playbook which has helped develop the world’s largest advanced therapy manufacturing footprint. Actively serves on multiple boards including academic, philanthropic, biotech, and financial investment institutions.

Anshul-Mangal
Anshul Mangal

President, Manufacturing Solutions

Groundbreaking biotech entrepreneur, executive, and investor, dedicated to delivering transformative treatments to the patients who need them. Pioneered the industrialization of advanced therapeutics, including some of the earliest commercially approved cell and gene therapies, radioligand treatments, RNA-based therapies, and cutting-edge biologics. Created the leading global biologics and advanced therapy engineering consulting firm and developed the largest cell and gene therapy manufacturing footprint in the world. Deeply committed to advancing next-generation medicines, serves on multiple boards, philanthropic organizations, and patient-advocacy groups, including IQHQ, Alliance for Regenerative Medicines, and Alliance for mRNA Medicines.

Scott Marshall
Scott Marshall, PhD

President, QuartzBio

Industry authority on precision medicine-guided strategy and development, particularly in translational informatics, data science, and software development operations. Pioneer in SaaS management of complex streams of associated biomarker data and clinical sample inventories. Strategist across a variety of data-centric spaces, including development of complex biomarker signatures for use in patient selection.

Deb Phippard
Deborah Phippard, PhD

Chief Scientific Officer

Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy.

Harpreet-Singh_Square_Full
Harpreet Singh, MD

Chief Medical Officer

Industry-leading oncologist and demonstrated medical leader in precision medicine, novel trial design and innovative regulatory initiatives designed to expedite drug approvals. Draws on nearly a decade leading oncology and rare disease programs at the FDA. Former fellow at the National Cancer Institute and frequent featured speaker at ASCO and AACR. CDER technical authority on oncologic drug and biological products for thoracic and head and neck malignancies, neurologic tumors, pediatric solid tumors and rare tumors.

Sofia Baig
Sofia Baig

President

Exceptional strategic leader, adept at driving organizational change and delivering top- and bottom-line business growth. Expert in strategic account management, global clinical development operations, and delivering transformational change inclusive of people, processes, and technology. Winner of multiple prestigious awards, including PharmaVoice 100 most inspiring leader in the life sciences industry, and as part of a team, the Catalyst Award for DEI work focused on improving women’s representation in senior leadership.

Harpreet-Singh_Square_Full
Harpreet Singh, MD

Chief Medical Officer

Industry-leading oncologist and demonstrated medical leader in precision medicine, novel trial design and innovative regulatory initiatives designed to expedite drug approvals. Draws on nearly a decade leading oncology and rare disease programs at the FDA. Former fellow at the National Cancer Institute and frequent featured speaker at ASCO and AACR. CDER technical authority on oncologic drug and biological products for thoracic and head and neck malignancies, neurologic tumors, pediatric solid tumors and rare tumors.

Nithiyanandhan-Ananthakrishnan-1
Nithiya Ananthakrishnan

Senior Vice President, Biometrics

Visionary executive with a distinguished track-record fostering an environment of continuous innovation and growth through people-centric strategies. Data sciences leader focused on data analysis, visualization, and solutions to solve key issues in clinical trials. On a personal level, deeply committed to supporting educational excellence, particularly for underprivileged children.

Andrea Cotton
Andrea Cotton-Berry

Global Head of Strategic Development

Notable authority in global operations, dedicated to fostering team spirit of excellence and collaboration with internal and external partners. Veteran of the quest to improve oncology therapies and extend lives, including 15+ years in oncology drug development, building on 10 years in obstetrics and women’s health.

Simon-Fleming
Simon Fleming

Executive Vice President

Veteran of the pharmaceutical industry, fluent in all aspects of clinical trial management, including business development, strategic operations, process improvement, technology implementation and finance. Special focus on global quality management, data management, biostatistics and statistical programming operations.

Carolyn Harley
Carolyn Harley

Head Operational Excellence

Seasoned industry veteran focused on maximizing operational quality and efficiency across clinical research through people, process, and technology. Leads technical and process support for clinical systems, ensures strategic resource management, develops preferred provider relationships, and manages vendor governance activities.

Katie-McGuire
Katie McGuire

Senior Vice President, Regulatory and Site Start-Up

Seasoned pharma leader with extensive expertise in oncology drug development and early phase clinical development. Veteran across multiple therapeutic indications in a wide range of multi-country, full-service studies through every phase. Strong communicator and trained executive coach who thrives on change and excels under pressure.

Clare Fourrier
Clare Sarvary Fourrier

Senior Vice President, Clinical Operations

Veteran of global oncology clinical operations, with in-depth experience in phase 1-3 oncology and hematology research as well as early-phase studies. Builder of world-class oncology research teams and leader of strategic growth of resources and operations across Europe. Keenly focused on study delivery, mitigation of study risk, and client service.

SallyAnne Williams
Sallyanne Williams

Senior Vice President, Global Head Project Management

Long-standing project management leader dedicated to improving delivery across all phases of product development. Working on a global scale, applies strategic smarts to operational delivery and financial management. Recognized as one of the PharmaVoice 100, some of the industry’s most inspiring people, awarded in the “Change Agent” category.

Matt-Arnold-1
Matt Arnold

President

Strategic, highly collaborative biotechnology industry veteran, driven by opportunities to bring life-changing therapeutics to patients. Over two decades of global, cross-functional biotech and pharmaceutical experience, across both rapid growth and mature organizations, including leadership positions at AVROBIO, AstraZeneca, and Amgen.

Deb Phippard
Deborah Phippard, PhD

Chief Scientific Officer

Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy.

YvoneBeasly
Yvonne Beasley

Vice President, Global Central Lab Services

Trusted industry leader with extensive experience in end-to-end biospecimen operational management, developing and leading operational teams of all sizes across multiple labs on a global scale. Deep knowledge of regulatory requirements. Delivery of operational excellence ensuring standardized processes and reliable and secure procedures for quality and efficiency.

Joe Bower
Joe Bower, PhD, MBA

Senior Vice President, Laboratory Operations

Experienced senior leader spanning the academic, pharmaceutical, and CRO industries. Specific expertise in biotherapeutics and vaccines for preclinical and clinical development programs and in identifying the appropriate immunochemistry assays for new development programs. Broad record of accomplishment leading global teams, delivering business strategies, expanding business, and ensuring operational excellence.

Darren Davis
Darren Davis, PhD

Senior Vice President

Visionary leader with decades of distinguished biotechnology and clinical translational research experience. Founded ApoCell in 2004 and later was instrumental in developing and commercializing the ApoStream® rare-cell liquid biopsy technology. Globally recognized cancer researcher and the author of more than 100 peer-reviewed publications. Dedicated and committed to improving the lives of patients with debilitating diseases.

Rob Fannon Headshot
Rob Fannon, MPH, MBA

General Manager, Biospecimen Solutions

Respected veteran of the biospecimen and biomarker laboratory services industry. Honed his expertise through leadership roles in organizations including Roche, Cancer Genetics, and BioServe. Holds a Master of Public Health and a Masters of Business Administration from the Johns Hopkins University.

Sven Olek
Sven Olek, PhD

Senior Vice President, Research

Inventor, industry expert, founder and leader of Epiontis. Developed the patents forming the basis of Epiontis’s intellectual property. Conducted pre- and postdoctoral research at the Center for Molecular Biology and Biomedicine (ZMBH) of the University of Heidelberg, Germany and the R.W. Johnson Pharmaceutical Research Institute, San Diego, California, USA. Received a BSc from the Imperial College of Science, Technology, and Medicine, London, and a PhD in Biochemistry from the University of London.

Amanda Woodroofe
Amanda Woodrooffe, PhD

Senior Vice President, General Manager UK Labs

Experienced leader of scientific operations for drug discovery in both the pharmaceutical and CRO industries. Driven to provide actionable data enabling biopharmaceutical research and development. Collaborative partner ensuring licensing and scientific support for corporate development initiatives.

Anshul-Mangal
Anshul Mangal

President

Groundbreaking biotech entrepreneur, executive, and investor, dedicated to delivering transformative treatments to the patients who need them. Pioneered the industrialization of advanced therapeutics, including some of the earliest commercially approved cell and gene therapies, radioligand treatments, RNA-based therapies, and cutting-edge biologics. Created the leading global biologics and advanced therapy engineering consulting firm and developed the largest cell and gene therapy manufacturing footprint in the world. Deeply committed to advancing next-generation medicines, serves on multiple boards, philanthropic organizations, and patient-advocacy groups, including IQHQ, Alliance for Regenerative Medicines, and Alliance for mRNA Medicines.

John Khoury
John Khoury

Executive Vice President

Long-standing biotech/pharmaceutical industry executive and global authority in cell and gene therapy facility builds. Key force in industrializing the world’s largest CGTx manufacturing footprint. Trusted strategic partner in make vs buy analysis, site and vendor selection, tech transfer execution strategies, and facility start-ups. Facilitated partnerships with 100+ life science organizations including startups, established biologics and CGTx innovators. Extensive experience with small and large molecules, including biologics and biosimilars. Dedicated champion for patient advocacy and philanthropy, who leads his team in contributing thousands of volunteer hours in support of patient-focused not-for-profit organizations.

Tony Khoury
Tony Khoury

Executive Vice President

Life sciences leader who helped pioneer the industrialization of biologics and advanced therapies. Deep expertise in small and large molecules, honed through work with a range of life science organizations, from start-ups and academic centers to financial institutions and CMOs/CROs. Spearheaded significant global turnkey facility builds, automation, validation, engineering, and serialization track and trace, deploying billions in capital across the life sciences sector. Led the creation of the Advanced Therapy Manufacturing Playbook which has helped develop the world’s largest advanced therapy manufacturing footprint. Actively serves on multiple boards including academic, philanthropic, biotech, and financial investment institutions.

Landon-DeCosta
Landon DeCosta

Senior Director

Noted leader, responsible for multiple cross-functional, multi-disciplinary teams across large capital projects, facility builds, engineering and validation both internationally and domestically in the pharmaceutical, biotech and advanced therapy industries. Scaled up manufacturing for one of the first-ever advanced therapies, including leading the commissioning and qualification efforts for a state-of-the-art viral vector facility build.

Daniel-Foody
Danny Foody

Director

Respected technical and quality advisor to both start-ups and established pharmaceutical companies for CMO/CDMO operational readiness capabilities. Subject matter expert in designing, implementing, and maintaining cGMP facilities. Has led multiple capital projects for partners in the advanced therapies and biologics spaces.

Greg Gara
Greg Gara

Senior Vice President

Seasoned biotechnology executive, focused on gene therapy. Deep experience designing, constructing, starting up and licensing manufacturing facilities around the globe. Broad leadership responsibility across TechOps/CMC including manufacturing, engineering, quality, and program management, both at site and global levels.

Jacob-Greenwood
Jacob Greenwood

Vice President

Strategic leader, creating and fostering client relationships and building brand awareness within the pharmaceutical and biotech industries. Leverages expertise gained delivering projects within the architecture, engineering, and construction industries. Formerly an active member of the preclinical research community, managing vivariums in both Maryland and North Carolina. Deeply committed to helping medicines and therapies move through the research and development stage into manufacturing and ultimately to market, impacting the lives of patients.

Christian-Hermanas
Christian Hermanas

Sr. Manager, Precision for Medicine Manufacturing Solutions

Kathy-Johnson
Kathy Johnson

Director of Human Resources

Human Resources expert with experience across a wide variety of industries. Leads with a “People First” mentality. Ensures strategic business goals align with employee initiatives across the organization. Spearheads resourcing, talent management, performance management, and employee engagement and retention.

Phillip-Massey1
Phil Massey

Senior Director

Trusted life sciences authority leading integrated teams in biologics, blood therapies and next generation medicines. Spearheads task forces focused on technical strategy and execution related to compliant pre-clinical, clinical, and commercial manufacturing. Directs agile teams across a range of functional areas spanning project management, facilities, infrastructure, process equipment, manufacturing operations, and quality projects.

joe-neroni
Joseph Neroni

Senior Director

Recognized leader in the biologics and advanced therapies industry, supporting cross-functional teams while building gene therapy facilities for some of the first-ever commercially approved therapies. Brings a strong technical background in upstream, downstream and fill and finish processes throughout the project life cycle from conceptual design through implementation. Demonstrated success delivering program and project management through turnkey facility builds, automation, validation, and engineering.  

Adam-Pfeiffer
Adam Pfeiffer

Vice President

Executive with long-standing life sciences consulting experience. Supported countless drug manufacturers in bringing life-saving therapies to the market, with an emphasis on engineering and qualification in the advanced therapy and large-molecule biologics space. Focused on overall business strategy, aligning operations, marketing, and business development groups in growing global life sciences partnerships.

Austin-Potthoff
Austin Potthoff

Manager, Precision for Medicine Manufacturing Solutions

Cory-Proctor
Cory Proctor

Senior Director

Experienced specialist in capital projects, medical device, and validation across the pharmaceutical, biotechnology and gene therapy industries. Directed diverse, cross-functional teams throughout the entire project lifecycle, spanning project initiation/funding requests, business case development, conceptual design, basis of design, detailed design, construction, commissioning/qualification, validation, and project close-out/purchase order closure.

Chad-Salisbury
Chad Salisbury

Senior Vice President

Industry veteran with deep experience in gene therapy, vaccines, sterile injectables, and small molecules. Delivered ~$2B in greenfield cGMP manufacturing facilities. Global responsibility in manufacturing, quality, engineering, and supply chain delivery. Singularly focused on using innovations in gene therapy to lead the fight against devastating rare and prevalent diseases.

Michelle-Sinsel
Michelle Sinsel

Senior Director

Notable expert in computer system validations, QC instrument qualification, data integrity solutions and remediations, and equipment qualification. Leads high performing CQV teams, mentors peers, creates validation strategies, provides subject matter expertise for data integrity initiatives, and manages project accounts.

Sarah-Stoll
Sarah Stoll

Senior Director

Authority in capital projects, operational strategy, and execution across the pharmaceutical, biotechnology, and gene therapy Industries. Adept at project initiation/funding requests, business case development, conceptual design, basis of design, detailed design, construction, commissioning and qualification, validation, project close-out/purchase order closure. Master at combining expert knowledge, industry experience, and relentless energy to resolve potential roadblocks and produce solutions throughout the entire project lifecycle.

Nathan-Traughber
Nathan Traughber

Senior Director

Sought-after leader with strong multidisciplinary background in engineering, validation, quality, manufacturing, and infrastructure. Proven track record of successful engineering project management in an FDA-regulated environment, able to support strategic planning and execution of significant manufacturing expansions. Focus on GMP engineering projects, especially in advanced therapies.

Jim-Watson_Square_Full
Jim Watson

Vice President

Pharmaceutical industry veteran with extensive experience in high-purity utilities, large molecule biological processes and advanced therapies. Expert in early-phase manufacturing strategy, conceptual design, user requirement specifications, verification, validation, facility turnover, and facility operations. Trusted lead on operational and commercial readiness programs. Leader on the cell and gene therapy task force.

Scott Marshall
Scott Marshall, PhD

President, QuartzBio

Industry authority on precision medicine-guided strategy and development, particularly in translational informatics, data science, and software development operations. Pioneer in SaaS management of complex streams of associated biomarker data and clinical sample inventories. Strategist across a variety of data-centric spaces, including development of complex biomarker signatures for use in patient selection.

Tobias-Guennel
Tobi Guennel

Senior Vice President of Product & Chief Architect, QuartzBio

Translational informatics visionary and creator of SaaS solutions supporting clinical sample inventory and biomarker data management. Drives technology innovation across data-centric spaces from complex biomarker signatures for patient selection to enterprise software solutions for pharmaceutical and biotechnology companies. Leads innovation for product management, product development, software engineering, product support, technical professional services, and solutions engineering.

Jared Kohler-1
Jared Kohler

Senior Vice President of Operations, Project Management, and Customer Success - QuartzBio

Pioneer in SaaS solutions for biomarker data management with extensive expertise across translational research and biometrics operations in clinical studies. Subject matter expert in genomics. Focus on operations and project management. Authority in physical and virtual sample management, kitting, study logistics, assays, biomarker data management, clinical data management, EDC builds, biostatistics, and companion diagnostics.

Messina Wiley
Messina Wiley

Senior Vice President of Sales & Marketing - QuartzBio

Marketing authority focused on developing strategic initiatives that build market value, create new business opportunities, and generate revenue growth. Skilled across all aspects of brand development, demand generation, competitive analysis, and product differentiation to amplify customer acquisition strategies. Working cross-functionally, creates go-to-market, product positioning and communications plans that move the needle.